Works matching IS 00071188 AND DT 2025 AND VI 182 AND IP 4

Results: 13

Genetic polymorphisms influencing antihypertensive drug responses.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 4, p. 929, doi. 10.1111/bph.17414

By:

El Cheikh, Jana;
Hamed, Fouad;
Rifi, Hana;
Dakroub, Ali H.;
Eid, Ali Hussein

Publication type:

Article

EXPRESSION OF CONCERN: Dose‐Dependent Biphasic Leptin‐Induced Proliferation is Caused by Non‐Specific IL‐6/NF‐κB Pathway Activation in Human Myometrial Cells.

Published in:: British Journal of Pharmacology, 2025, v. 182, n. 4, p. 1121, doi. 10.1111/bph.17430
Publication type:: Article

Dual effects of DLG5 (disks large homolog 5 gene) modulation on chemotherapy‐induced thrombocytopenia and nausea/vomiting via the hippo signalling pathway.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 4, p. 1090, doi. 10.1111/bph.17391

By:

Li, Mingming;
Wang, Rong;
Yan, Tao;
Tao, Xia;
Gao, Shouhong;
Wang, Zhipeng;
Chai, Yunsheng;
Qiu, Shi;
Chen, Wansheng

Publication type:

Article

Dual effects of mefenamic acid on the I<sub>Ks</sub> molecular complex.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 4, p. 1075, doi. 10.1111/bph.17389

By:

Chan, Magnus;
Pourrier, Marc;
Eldstrom, Jodene;
Sahakyan, Harutyun;
Vardanyan, Vitya;
Fedida, David

Publication type:

Article

The expression of contextual fear conditioning involves the dorsal hippocampus TRPV1 receptor interacting with the NMDA/NO/cGMP signalling pathway.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 4, p. 1107, doi. 10.1111/bph.17384

By:

Bertacchini, Gabriela L.;
Sonego, Andreza B.;
Lisboa, Sabrina F.;
Lagatta, Davi C.;
Resstel, Leonardo B. M.

Publication type:

Article

Cognitive improvement via cortical cannabinoid receptors and choline‐containing lipids.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 4, p. 1038, doi. 10.1111/bph.17381

By:

Moreno‐Rodríguez, Marta;
Martínez‐Gardeazabal, Jonatan;
Bengoetxea de Tena, Iker;
Llorente‐Ovejero, Alberto;
Lombardero, Laura;
González de San Román, Estibaliz;
Giménez‐Llort, Lydia;
Manuel, Iván;
Rodríguez‐Puertas, Rafael

Publication type:

Article

Sex influence on serotonergic modulation of the vascular noradrenergic drive in rats.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 4, p. 1025, doi. 10.1111/bph.17380

By:

Terol‐Úbeda, Anaïs Clara;
Fernández‐González, Juan Francisco;
Roldán‐Hernández, Carlos Andrés;
Martín, María Luisa;
Morán, Asunción;
García‐Domingo, Mónica;
García‐Pedraza, José Ángel

Publication type:

Article

Dihydro‐resveratrol ameliorates NLRP3 inflammasome‐mediated neuroinflammation via Bnip3‐dependent mitophagy in Alzheimer's disease.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 4, p. 1005, doi. 10.1111/bph.17373

By:

Tao, Guorong;
Wang, Xuebao;
Wang, Jian;
Ye, Yiru;
Zhang, Minxue;
Lang, Yan;
Ding, Saidan

Publication type:

Article

Slow dissociation kinetics of fentanyls and nitazenes correlates with reduced sensitivity to naloxone reversal at the μ‐opioid receptor.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 4, p. 969, doi. 10.1111/bph.17376

By:

Alhosan, Norah;
Cavallo, Damiana;
Santiago, Marina;
Kelly, Eamonn;
Henderson, Graeme

Publication type:

Article

Salvianolic acid B improves the microcirculation in a mouse model of sepsis through a mechanism involving the platelet receptor CD226.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 4, p. 988, doi. 10.1111/bph.17371

By:

Li, Xuemei;
Liu, Shanshou;
Xie, Jiangang;
Liu, Lin;
Duan, Chujun;
Yang, Lu;
Wang, Yuling;
Wu, Yilin;
Shan, Niqi;
Zhang, Yun;
Zhang, Yuan;
Zhuang, Ran

Publication type:

Article

Mu‐opioid receptors in tachykinin‐1‐positive cells mediate the respiratory and antinociceptive effects of the opioid fentanyl.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 4, p. 1059, doi. 10.1111/bph.17369

By:

Furdui, Andreea;
da Silveira Scarpellini, Carolina;
Montandon, Gaspard

Publication type:

Article

QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age‐related macular degeneration.

Published in:

British Journal of Pharmacology, 2025, v. 182, n. 4, p. 951, doi. 10.1111/bph.17362

By:

Arokiasamy, Samantha;
Balderstone, Michaela J. M.;
Shaik, Faheem;
Cristante, Enrico;
Moseley, Thomas C.;
Madoo, Akshay;
Rizzi, Matteo;
Bainbridge, James W.;
Tsoyi, Konstantin;
Rosas, Ivan O.;
Whiteford, James R.;
De Rossi, Giulia

Publication type:

Article

Issue Information.

Published in:: British Journal of Pharmacology, 2025, v. 182, n. 4, p. 927, doi. 10.1111/bph.16445
Publication type:: Article